Advertisement
Advertisement
FATE
Fate Therapeutics, Inc.
1.77
USDSponsored
-0.17
-8.76%
Nov 10, 15:57 UTC -5
Closed
After-Market
1.77
0.00
0.00%
Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. Financial Snapshot
| Market Cap | 215.18M |
| Beta | 2.65 |
| Earnings Per Share (EPS) | -1.03 |
| Price-to-Book (P/B) Ratio | 1.59 |
| Operating Margin | -1941.09% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -65.08% |
| Current Ratio | 4.41% |
| Free Cash Flow | -82.47M |
